It is our assumption that specialists in weight management and nutrition will have better outcomes than a primary care doctor that treats every disease
The specific use cases are worth spelling out: A self-insured employer benefit consultant can use patent expiration data to identify which of their high-cost brand drugs will have generic alternatives within 12-24 months, and plan formulary transitions accordingly
Data highlights from the ACHIEVE-1 Phase III trial for Eli Lilly's GLP-1 At 40 weeks, Eli Lilly's orforglipron enabled a superior reduction in A1C compared to placebo
These include congenital melanocytic nevi (CMN) and acquired melanocytic nevi (AMN), dysplastic nevi, Spitz nevi, Becker nevi, halo nevi, blue nevi, and nevus spilus
Patients on GLP-1 medications should never drink on an empty stomach and should always consume carbohydrate-rich food alongside any alcoholic beverage